Market Place
Sourcing Support
Pfizer tabs controversial Chinese firm Huahai to make Paxlovid
24 Aug 2022 //
FIERCEPHARMA
Pfizer Picks China Firm Involved in Drug Recall for Covid Pill
23 Aug 2022 //
BLOOMBERG
Biocon-Viatris, AstraZeneca, Huhai and more—Fierce Pharma Asia
19 Nov 2021 //
FIERCEPHARMA
Valsartan recall protagonist comes off FDA warning letter
16 Nov 2021 //
FIERCEPHARMA
EMA, FDA begin reviewing heartburn medicines for carcinogen
17 Sep 2019 //
ENDPTS
US officials worried about Chinese control of American drug supply
13 Sep 2019 //
NBCNEWS
Fourth Carcinogen Discovered in Heart Pills Used by Millions
19 Jun 2019 //
BLOOMBERG
EMA Urges Pioglitazone Manufacturers to Check for Nitrosamine Impurities
26 Apr 2019 //
RAPS
FDA`s Gottlieb defends agency response to valsartan contamination
22 Mar 2019 //
BIOPHARMA DIVE
The FDA again adds more drugs to its valsartan recall list
25 Oct 2018 //
CNN
Embattled Chinese drug maker to get $43 million in government support
15 Oct 2018 //
CHINA TODAY ONLINE
Litigation teaches Chinese valsartan maker the downside of U.S. market
10 Oct 2018 //
FIERCE PHARMA
Tainted heart drug from second Chinese firm pulled off EU market
21 Aug 2018 //
ECONOMIC TIMES
Torrent Pharma recalls 14 lots of blood pressure drug in US
20 Aug 2018 //
HINDU BUSINESS LINE
EU Suspends Chinese Company From Manufacturing Valsartan Active Substances
20 Aug 2018 //
RAPS
CDSCO port offices keep close eye on valsartan API imports after US recall
11 Aug 2018 //
PHARMABIZ
India`s Hetero pulls heart drug from U.S. amid cancer risk probes
11 Aug 2018 //
ECONOMIC TIMES
Red Flags Raised at Chinese Heart Drug Maker Year Before Recall
10 Aug 2018 //
BLOOMERG
Safety advisory - products in Australia not affected by overseas recalls
09 Aug 2018 //
TGA
Two more Chinese pharma groups hit by drugs scandal
07 Aug 2018 //
ASIATIMES
DRAP directs drug manufacturers to recall products of Zheijiang Huahai
07 Aug 2018 //
NATION PK
The contamination of a popular blood-pressure medicine is now a global problem
07 Aug 2018 //
QUARTZ
EU sees one in 5,000 cancer risk from tainted China heart drug
03 Aug 2018 //
REUTERS
EMA Updates on Recalled Valsartan Medicines
02 Aug 2018 //
RAPS
Update on review of recalled valsartan medicines
31 Jul 2018 //
EMA
China’s pharma scandals sully healthcare cleanup
23 Jul 2018 //
REUTERS
Pfizer Indian plant hassle, China-India pharma bond, Sinovant debut
20 Jul 2018 //
FIERCE PHARMA
India launches probe as Chinese company recalls BP drug
20 Jul 2018 //
ECONOMIC TIMES
India launches probe as China co recalls BP drug
19 Jul 2018 //
ECONOMIC TIMES
Zhejiang Huahai`s unit to buy Par Pharmaceutical`s factory in North Carolina
06 Dec 2016 //
REUTERS
China rejects 11 drug applications over inadequate trial data
12 Nov 2015 //
REUTERS
